Vapreotide: BMY 41606, RC 160, Sanvar®

ISSN： 1174-5886

Source： Drugs in R&D, Vol.4, Iss.5, 2003-01, pp. : 326-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Satraplatin: BMS 182751, BMY 45594, JM 216

By Adis International Limited

Drugs in R&D, Vol. 8, Iss. 2, 2007-01 ,pp. : 125-132

Adis International

Access to resources Recommend Favorite

Satraplatin: BMS 182751, BMY 45594, JM 216

Drugs in R&D, Vol. 3, Iss. 1, 2002-01 ,pp. : 67-71

Adis International

Access to resources Recommend Favorite

BMY 7378 is a selective antagonist of the D subtype of 1 -adrenoceptors

By Goetz A.S. King H.K. Ward S.D.C. True T.A. Rimele T.J. Saussy D.L.

European Journal of Pharmacology, Vol. 272, Iss. 2, 1995-01 ,pp. : 5-6

Elsevier

Access to resources Recommend Favorite

In vitro and in vivo evidence for a tachykinin NK 1 receptor antagonist effect of vapreotide, an analgesic cyclic analog of somatostatin

By Betoin F. Advenier C. Fardin V. Wilcox G. Lavarenne J. Eschalier A.

European Journal of Pharmacology, Vol. 279, Iss. 2, 1995-06 ,pp. : 241-249

Elsevier

Access to resources Recommend Favorite

5-HT 1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus

By Matos F.F. Korpinen C. Yocca F.D.

European Journal of Pharmacology, Vol. 317, Iss. 1, 1996-12 ,pp. : 49-54

Elsevier

Access to resources Recommend Favorite